Free Trial
NASDAQ:NRXS

NeurAxis (NRXS) Stock Price, News & Analysis

NeurAxis logo
$5.18 -0.25 (-4.52%)
As of 10:05 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About NeurAxis Stock (NASDAQ:NRXS)

Advanced

Key Stats

Today's Range
$5.11
▼
$5.42
50-Day Range
$5.42
▼
$7.92
52-Week Range
$2.21
▼
$9.33
Volume
75,431 shs
Average Volume
135,823 shs
Market Capitalization
$55.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00
Consensus Rating
Moderate Buy

Company Overview

NeurAxis, Inc. is a medical technology company focused on developing neuromodulation therapies for chronic and functional pain conditions. Its approach uses percutaneous electrical nerve field stimulation (PENFS), which delivers mild electrical impulses through nerves associated with the brain-gut pathway.

The company’s lead product, IB-Stim, is a wearable, minimally invasive device cleared by the U.S. Food and Drug Administration for use as an adjunctive treatment for functional abdominal pain associated with irritable bowel syndrome in patients ages 11 to 18 who have not responded to conventional therapy. Treatment is delivered over a four-week period.

NeurAxis markets its therapies in the United States and continues to develop neuromodulation treatments for gastrointestinal and related conditions.

AI Generated. May Contain Errors.

NeurAxis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

NRXS MarketRank™: 
2.747843397475 of 5 stars

NeurAxis scored higher than 55% of companies evaluated by MarketBeat, and ranked 463rd out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    NeurAxis has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.

  • Upside Potential

    NeurAxis has a consensus price target of $13.00, representing about 150.5% upside from its current price of $5.19.

  • Amount of Analyst Coverage

    NeurAxis has only been the subject of 1 research reports in the past 90 days.

  • Read more about NeurAxis' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NeurAxis is -2.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NeurAxis is -2.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for NRXS.
  • Dividend Yield

    NeurAxis does not currently pay a dividend.

  • Dividend Growth

    NeurAxis does not have a long track record of dividend growth.

  • News Sentiment

    NeurAxis has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for NeurAxis this week, compared to 1 article on an average week.
  • Cluster Insider Buying

    3 insiders have purchased shares of NeurAxis in the last three months. Multiple insiders buying is a strong bullish signal.

  • Net Insider Buying

    Over the last three months, insiders have purchased a net $12,260.00 in company stock, which represents 0.0222% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, NeurAxis insiders have bought more of their company's stock than they have sold. Specifically, they have bought $12,260.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    21.10% of the stock of NeurAxis is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    11.77% of the stock of NeurAxis is held by institutions.

  • Read more about NeurAxis' insider trading history.
Receive NRXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeurAxis and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NRXS Stock News Headlines

What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
NeurAxis (NRXS) Q3 2026 Earnings Call Transcript
NeurAxis (NRXS) Projected to Announce Quarterly Earnings on Monday
See More Headlines

NRXS Stock Analysis - Frequently Asked Questions

NeurAxis' stock was trading at $4.54 at the beginning of the year. Since then, NRXS stock has increased by 14.3% and is now trading at $5.19.

NeurAxis, Inc. (NASDAQ:NRXS) announced its earnings results on Tuesday, November, 12th. The company reported ($0.25) EPS for the quarter. The firm earned $670 thousand during the quarter.

NeurAxis (NRXS) raised $7 million in an initial public offering (IPO) on Wednesday, August 9th 2023. The company issued 1,098,667 shares at a price of $6.00 per share.

NeurAxis' top institutional shareholders include AIGH Capital Management LLC (4.30%), Money Concepts Capital Corp (1.88%), State Street Corp (0.38%) and T3 Companies LLC (0.22%). Insiders that own company stock include Gil Aharon, Brian Allen Carrico, Thomas Joeseph Carrico, Timothy Robert Henrichs and Corp Masimo.
View institutional ownership trends
.

Shares of NRXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:NRXS
CIK
1933567
Fax
N/A
Employees
24
Year Founded
2011

Price Target and Rating

High Price Target
$13.00
Low Price Target
$13.00
Potential Upside/Downside
+150.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.63 million
Net Margins
-492.76%
Pretax Margin
-341.35%
Return on Equity
N/A
Return on Assets
-641.25%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.24
Quick Ratio
0.23

Sales & Book Value

Annual Sales
$6.53 million
Price / Sales
8.46
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.27) per share
Price / Book
-19.22

Miscellaneous

Outstanding Shares
10,653,000
Free Float
6,085,000
Market Cap
$55.29 million
Optionable
Optionable
Beta
1.39

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:NRXS) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners